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and Joshua R. Sanes2
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Department of Cell and Developmental Biology, State University of New York Upstate Medical University, Syracuse, NY 13210



-Dystrobrevin (DB), a cytoplasmic component of the
dystrophin–glycoprotein complex, is found throughout
the sarcolemma of muscle cells. Mice lacking DB exhibit
muscular dystrophy, defects in maturation of neuromuscular
junctions (NMJs) and, as shown here, abnormal myotendinous junctions (MTJs). In normal muscle, alternative splicing
produces two main DB isoforms, DB1 and DB2, with
common NH2-terminal but distinct COOH-terminal domains.
DB1, whose COOH-terminal extension can be tyrosine
phosphorylated, is concentrated at the NMJs and MTJs.
DB2, which is not tyrosine phosphorylated, is the predominant isoform in extrajunctional regions, and is also

present at NMJs and MTJs. Transgenic expression of either
isoform in DB/ mice prevented muscle ﬁber degeneration;
however, only DB1 completely corrected defects at the
NMJs (abnormal acetylcholine receptor patterning, rapid
turnover, and low density) and MTJs (shortened junctional
folds). Site-directed mutagenesis revealed that the effectiveness of DB1 in stabilizing the NMJ depends in part on its
ability to serve as a tyrosine kinase substrate. Thus, DB1
phosphorylation may be a key regulatory point for synaptic
remodeling. More generally, DB may play multiple roles
in muscle by means of differential distribution of isoforms
with distinct signaling or structural properties.

Introduction
The dystrophin–glycoprotein complex (DGC),* which is
found throughout the sarcolemma of skeletal muscle cells,
forms a multimolecular, transmembrane link between the
intracellular cytoskeleton and the extracellular basal lamina
(Ervasti and Campbell, 1993). Constituents of the DGC
include dystrophin, utrophin, dystroglycans ( and ),
sarcoglycans (, , , , and ), syntrophins (1, 1, and
2), dystrobrevins (DBs;  and ), and sarcospan (Ervasti et
al., 1990; Yoshida and Ozawa, 1990; for review see Blake et
al., 2002). Interest in the DGC stemmed originally from the
finding that mutations in genes encoding numerous DGC
Address correspondence to R. Mark Grady, Dept. of Pediatrics, Washington University School of Medicine, Pediatric Research Bldg., St.
Louis, MO 63110. Tel.: (314) 286-2796. Fax: (314) 286-2892. E-mail:
grady@kids.wustl.edu
*Abbreviations used in this paper: AChR, acetylcholine receptor; DB,
dystrobrevin; DGC, dystrophin–glycoprotein complex; MTJ, myotendinous
junction; NMJ, neuromuscular junction; nNOS, nitric oxide synthase;
rBTX, rhodamine -bungarotoxin.
Key words: dystrobrevin; dystrophin; muscular dystrophy; myotendinous
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components cause muscular dystrophy: loss of dystrophin
results in Duchenne muscular dystrophy; deficiencies in four
of the sarcoglycans have been linked to limb-girdle muscular
dystrophies; and mutations in laminin  2, the main extracellular ligand for the DGC, lead to congenital muscular
dystrophy (Cohn and Campbell, 2000; Blake et al., 2002).
In addition to its role in myofiber integrity, the DGC is
also important in formation or maintenance of two specialized
domains on the muscle fiber surface: neuromuscular junctions
(NMJs), at which motor axons innervate muscle fibers, and
myotendinous junctions (MTJs), at which muscle fibers
form load-bearing attachments to tendons. The DGC is
dispensable for initial steps in postsynaptic differentiation,
but contributes importantly to the maturation and stabilization
of the postsynaptic membrane. For example, myotubes lacking
dystroglycan, utrophin, 1-syntrophin, or DB have alterations in the density and patterning of acetylcholine receptors
(AChRs) embedded within the postsynaptic membrane
(Deconinck et al., 1997a; Grady et al., 1997a, 2000; Adams
et al., 2000; Jacobson et al., 2001; Akaaboune et al., 2002).
Roles of the DGC have been less extensively studied at the

741

Downloaded from jcb.rupress.org on January 4, 2012

The Journal of Cell Biology

1

Published February 25, 2003

MTJ, but several DGC components are concentrated in this
region (e.g., dystrophin, utrophin, syntrophin, sarcospan,
and nNOS [Chen et al., 1990; Byers et al., 1991; Khurana
et al., 1991; Chang et al., 1996; Crosbie et al., 1999]), and
MTJs are structurally abnormal in mice lacking dystrophin
or both dystrophin and utrophin (Ridge et al., 1994; Deconinck et al., 1997b).
Little is known about how the DGC plays these disparate
roles, but one important factor is that its composition varies
among cell types (Straub et al., 1999; Loh et al., 2000;
Moukhles and Carbonetto, 2001) and, for muscle cells at
least, from site to site within a single cell. In muscle fibers,
dystrophin is present throughout the sarcolemma, whereas its
autosomal homologue, utrophin, is confined to the NMJ and
MTJ (Khurana et al., 1991; Ohlendieck et al., 1991). Likewise, each of the three syntrophins has a distinct sarcolemmal
distribution (Kramarcy and Sealock, 2000). Here, we focus
on another DGC component, DB, to address the issue of
how isoform diversity contributes to functional diversity.
DB is found throughout the sarcolemma in vertebrate skeletal muscle, where it binds dystrophin, utrophin, and syntrophin (Carr et al., 1989; Wagner et al., 1993; Peters et al.,
1997b, 1998; Sadoulet-Puccio et al., 1997). A homologue,
DB, has been described but is expressed at low levels if at all
in skeletal muscle (Peters et al., 1997a; Blake et al., 1998).
Previously, we showed that DB/ knockout mice exhibit
both muscular defects (muscular dystrophy) and abnormal
NMJs (Grady et al., 1999, 2000; Akaaboune et al., 2002). In
addition, we show here that DB/ mice have malformed
MTJs. Thus, DB influences DGC function at three distinct
locations within the muscle cell.
Several isoforms of DB are generated by alternative splicing, of which three, DB1–3, have been detected in skeletal
muscle (Blake et al., 1996; Sadoulet-Puccio et al., 1996;
Enigk and Maimone, 1999; Newey et al., 2001a) They are
identical over most of their length (551 aa) but have distinct
COOH termini (Fig. 1 A). The 188 aa COOH terminus of
DB1 is a substrate for tyrosine kinases in vivo (Wagner et
al., 1993; Balasubramanian et al., 1998), whereas common
sequences and the short (16 aa) COOH terminus of DB2
do not appear to undergo phosphorylation. DB3 lacks the
syntrophin- and dystrophin-binding sites present in the
other isoforms and has not been studied in detail. Although
both DB1 and DB2 are concentrated at the postsynaptic
membrane, their detailed localization differs within the
junction; furthermore, only DB2 is present at high levels
in extrasynaptic regions (Peters et al., 1998; Newey et al.,
2001a). Based on these differences, we hypothesized that
DB1 and DB2 might have distinct functions. In addition, based on evidence that tyrosine phosphorylation regulates the plasticity of neuron–neuron synapses (Ali and
Salter, 2001), we wanted to test the theory that tyrosine
phosphorylation of DB1 affects neuromuscular maturation
or structure.
To directly assess these ideas, we expressed DB1 or
DB2 in DB/ mice and analyzed the ability of each isoform to “rescue” the dystrophic, synaptic, and myotendinous phenotypes. We show that either DB1 or DB2 is
able to maintain muscle stability but that DB1 is signifi-

Figure 1. Generation of transgenic mice. (A) Structure of DB,
showing the two main isoforms expressed in muscle and the regions
recognized by anti-DB antibodies (pan-DB, DB1, and DB2). Also
shown are binding regions for syntrophin (SYN; hatched area) and
dystrophin (DYS; black area), sequences unique to DB2 (gray hatched
area), and sites in DB1 that undergo tyrosine phosphorylation in
vivo (P). (B) Immunoblot of whole muscle extracts stained with a
pan-DB antibody. Equal amounts (50 g) of protein were loaded for
each genotype (wt; wild-type). Molecular weight markers are shown
in kD. (C) Immunostaining of skeletal muscle from the four genotypes
with a pan-DB antibody. DB is expressed in 95% of muscle fibers
in both transgenic lines.

cantly better than DB2 in preventing synaptic and myotendinous defects. We also used sited-directed mutagenesis
to show that the enhanced efficacy of DB1 depends in part
on its tyrosine phosphorylation.

Results
Generation of transgenic mice
We generated transgenic mice in which regulatory elements
from the muscle creatine kinase gene were linked to cDNAs
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Figure 2. DB1 and DB2 both prevent muscle fiber degeneration
in DBⴚ/ⴚ mice. Hematoxylin and eosin–stained sections of
skeletal muscle from wild-type, DB/, DB/,tgDB1, and
DB/,tgDB2 mice. Regenerated muscle fibers are centrally
nucleated, indicating that some of the initial cohort of fibers had
degenerated. No histological evidence for muscle fiber degeneration
or regeneration was seen in either DB/ transgenic line. Insets
show high power images.

encoding DB1 or DB2. Transgenic mice were bred to
DB/ mice (Grady et al., 1999, 2000). We studied two
transgenic lines that expressed DB1 (12 and 14) and three
that expressed DB2 (11A, 11B, and 28). In the text and
figures, the designations tgDB1 and tgDB2 refer to lines 12
and 28, respectively. However, the main results were confirmed with the other lines (see Materials and methods).
Immunoblotting with antibodies that recognize all DB
isoforms showed that levels of transgene expression were
similar in the tgDB1 and tgDB2 lines (Fig. 1 B). Levels of
recombinant DB2 in DB/,tgDB2 were similar to levels
of endogenous DB2 in control mice, whereas levels of recombinant DB1 in DB/,tgDB1 muscle were significantly higher then levels of endogenous DB1 but similar to
levels of total DB in controls (Fig. 1 B). Immunohistochemical analysis showed that DB1 and DB2 were
present in 95% of all muscle fibers in DB/,tgDB1 and
DB/,tgDB2 mice, respectively (Fig. 1 C). In both lines,
the transgene was expressed in all skeletal muscles tested, including tibialis anterior, sternomastoid, and diaphragm, and
there were no detectable differences among fibers that correlated with fiber type (unpublished data).
Muscular dystrophy
DB/ mice exhibit a mild muscular dystrophy characterized by degenerating myofibers, infiltrating monocytes,
and centrally nucleated regenerating myotubes (Fig. 2)
(Grady et al., 1999). To test whether DB1 and DB2 differ in their ability to maintain muscular integrity, we examined
the diaphragm, quadriceps, soleus, sternomastoid, and tibialis
anterior muscles of DB/,tgDB1 and DB/,tgDB2
mice. The diaphragm provided a particularly stringent test
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Figure 3. Localization of DB isoforms in DBⴚ/ⴚ and mdx mice
expressing DB1 and/or DB2. Sections of skeletal muscle stained
with antibodies that recognize DB1, DB2, or both (pan-DB).
Sections were counterstained with rBTX to identify synaptic sites,
which are indicated by arrowheads. (A) In wild-type muscle, both
DB1 and 2 are enriched at the synapse, whereas DB2 is the
predominant extrasynaptic isoform. Both isoforms are absent from
DB/ muscle, although weak synaptic reactivity of unknown
molecular identity is seen using the DB2 antibody (Grady et al., 2000).
In DB/,tgDB1 and DB/,tgDB2 muscle, transgene-encoded
DB is present throughout the sarcolemma and enriched at synaptic
sites. For DB2, this pattern is similar to that seen in control muscle,
but the extrasynaptic abundance of transgenic DB1 is greater
than in controls. In DB/ muscle expressing both DB1 and 2
(DB/,tgDB1/DB2), extrasynaptic DB1 is retained and DB2
decreases. (B) In mice lacking dystrophin (mdx), sarcolemmal
expression of both isoforms is reduced. Likewise, only low levels of
extrasynaptic DB are present in mdx mice expressing recombinant
DB1 (mdx,DB /,tgDB1).
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744 The Journal of Cell Biology | Volume 160, Number 5, 2003

The Journal of Cell Biology

Downloaded from jcb.rupress.org on January 4, 2012
Figure 4. DB1 is better able than DB2 to restore normal AChR density and distribution to DBⴚ/ⴚ mice. (A) Longitudinal sections of
wild-type, DB/, DB/,tgDB1, and DB/,tgDB2 muscle stained with rBTX. In wildtype synapses, AChRs form multiple branches with
smooth borders. Within branches, AChRs are evenly distributed or faintly striated. In DB/ synapses, AChRs are patchily distributed with
fragmented branch borders and radiating spicules. In DB/,tgDB1 synapses, AChR pattern is essentially normal. In the majority of DB/,tgDB2
synapses, AChRs are patchily distributed, but spicules of AChRs at branch borders are shorter than those of mutants. (B) Synaptic density ( SE)
of AChRs in each of the four genotypes as assessed by their mean fluorescence intensity after incubation with a saturating dose of rBTX. AChR
density in DB/ synapses (n 49) is ⵑ30% of wild-type (n 18). At DB/,tgDB1 synapses (n 49), AChR density recovers to control
levels, whereas in DB/,tgDB2 synapses (n 19) density remains intermediate between wild-type and DB/. (C) High power images of
branches from synapses such as those shown in A to highlight differences in AChR patterning. Spicules are indicated by arrowheads.

because it is the most severely affected muscle in several
models of muscular dystrophy, including DB/ mice
(Stedman et al., 1991; Grady et al., 1997b, 1999; Duclos
et al., 1998). Rescue by both transgenes was dramatic. No
degenerating fibers, regenerating (centrally nucleated) fibers, or infiltration by monocytes were detected in any

muscles of either DB/,tgDB1 or DB/,tgDB2 mice
(Fig. 2 and unpublished data). This was true in mice ranging in age from 1–7 mo, in muscles with predominantly
fast (type IIB and II) fibers (tibialis anterior, quadriceps,
diaphragm, and sternomastoid), and in muscles with predominantly slow (type I and IIA) fibers (soleus). Thus, ei-
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Figure 5. DB1 is better able than
DB2 to restore normal AChR turnover
to DBⴚ/ⴚ mice. Turnover of AChRs as
assessed by the change in fluorescence
intensity in rBTX-labeled synapses over
a 3-d period. (A) Grayscale images used
to calculate t1/2. (B) AChRs in wild-type
synapses had an average t1/2 of ⵑ10.5 d
( SE, n 20), whereas those of DB/
synapses (n 56) were ⵑ2.5 d. AChR t1/2
in DB/,tgDB1 synapses (n 45) was
similar to that of control mice, whereas
t1/2 of DB/,tgDB2 synapses (n 33)
was intermediate between control and
DB/.

Synaptic localization of DB isoforms
We immunostained muscles with antibodies specific for
DB1 and DB2 (Fig. 1 A). Consistent with previous reports, both isoforms are present at higher levels at synaptic
sites (marked with rhodamine -bungarotoxin [rBTX],
which binds specifically and quasiirreversibly to AChRs)
than in extrasynaptic regions of the sarcolemma (Peters et al.,
1998; Grady et al., 2000). Likewise, recombinant DB1 and
DB2 were concentrated at synaptic sites in DB/,tgDB1
and DB/,tgDB2 mice, respectively (Fig. 3 A). For
DB2, the endogenous and recombinant proteins were distributed similarly. However, whereas endogenous DB1
was barely detectable extrasynaptically, recombinant DB1
was abundant extrasynaptically (Fig. 3 A). Thus, selective localization of DB1 to the NMJ in wild-type muscle cannot
be explained solely by its primary sequence.
The abundance of extrasynaptic DB1 in DB/,tgDB1
muscle might result from its higher than normal levels (Fig.
1 B). An alternative, however, is that restriction of DB1 to
synaptic sites requires the presence of DB2. For example,
DB2 might have a higher affinity than DB1 for extrasynaptic-binding sites and thereby displace DB1 from such
sites. To test this hypothesis, we generated doubly transgenic
DB/ mice that expressed DB1 and DB2 at similar
levels. In DB/,tgDB1/DB2 mice, DB2 was clearly
present extrasynaptically, but its presence failed to reduce extrasynaptic levels of DB1 (Fig. 3 A). Indeed, levels of
membrane-associated DB2 immunoreactivity were decreased when DB1 was present, suggesting that DB2 did
not bind selectively to extrasynaptic sites.
We also exploited the presence of extrasynaptic DB1 to
test whether DB1 depends on the DGC for its localization
to the sarcolemma. Levels of endogenous DB, primarily
DB2, are greatly reduced in extrasynaptic regions of dystrophin-deficient (mdx) mice (Grady et al., 1997b). However, there is evidence for dystrophin-independent associations of DB with the sarcolemma (Crawford et al., 2000),
and these associations might be sufficient to tether DB1 to
the membrane. We found that levels of extrasynaptic DB1
remained low in mdx,DB ,tgDB1 mice despite the

overexpression of recombinant DB1 (Fig. 3 B). Consistent with this result, there was no attenuation of dystrophic symptoms in mdx,DB ,tgDB1 compared with
mdx,DB  mice (unpublished data). Thus unique sequences in DB1 neither mediate a DGC-independent association with the membrane nor attenuate dystrophy in the
absence of dystrophin.
AChR distribution and density
Normal adult mouse NMJs are pretzel shaped with
an AChR-rich postsynaptic membrane underlying each
branch of the nerve terminal. DB deficiency does not
greatly affect the overall topology of the NMJ but does affect the arrangement of its AChRs in three ways (Fig. 4)
(Grady et al., 2000; Akaaboune et al., 2002). First, AChRs
smoothly outline each branch in controls, whereas branch
borders in mutants are fragmented with long finger-like
spicules that radiate beyond the terminal’s edge. Second,
AChRs in control NMJs are enriched along the crests of
the junctional folds that invaginate the postsynaptic membrane, leading to a striated appearance within each branch.
In DB/ synapses, in contrast, the distinction between
the crests and folds is blurred (shown ultrastructurally in
Grady et al., 2000) with receptors forming small, irregularly spaced aggregates or clumps. Finally, the density of
AChRs is reduced by ⵑ70% at DB/ synapses compared with controls.
Expression of DB1 in mice prevented all three of these
defects: AChR distribution and density were indistinguishable from normal at 95% of synaptic sites examined (Fig.
4). Thus, DB1 alone can support postsynaptic maturation.
In contrast, in DB/,tgDB2 mice examined at 4–6 wk
of age the postsynaptic membrane remained abnormal at
90% of synaptic sites: AChRs formed small aggregates
comparable to those seen at DB/ synapses rather than
the linear striations characteristic of normal muscle. On the
other hand, most DB/,tgDB2 postsynaptic sites were
distinguishable from those in mice lacking all DB, in that
spicules radiating from the edge of the AChR-rich region
were either absent or short and AChR density was slightly
but significantly greater than in mutants (Fig. 4, B and C).
Thus, DB2 supports normal postsynaptic maturation to a
lesser degree than DB1.
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Figure 6. Localization of DGC-associated proteins in DB mutant
and transgenic mice. Sections of skeletal muscle were stained with
antibodies to nNOS or 1-syntrophin (1-syn). In wild-type muscle,
nNOS and 1-syntrophin are present throughout the sarcolemma
with enrichment at the synaptic sites (arrowheads). In DB/ muscle,
membrane levels of both proteins were reduced. Expression of
DB1 restored normal levels of both proteins to DB/ muscle. In
DB/,tgDB2 muscle, levels of nNOS and 1-syntrophin remained
lower than normal at many sites.

The difference between DB/,tgDB1 and DB/,
tgDB2 synapses was also evident in 3–6-mo-old animals.
However, the percentage of normal-appearing synapses in
DB/,tgDB2 increased to ⵑ50% at 6 mo of age. This
age-related increase suggests that the continued presence of
even the relatively ineffective DB2 can eventually normalize the structure of initially abnormal synapses. Moreover, it
raises the possibility that differences between DB1 and
DB2 are quantitative rather than qualitative. In this regard,
it is important to note that levels of transgene expression
were similar in DB/,tgDB1 and DB/, DB2 mice
(Fig. 1 B). Moreover, studies of transfected muscle fibers,
described below, provide independent evidence that DB1specific sequences play a distinct role.
AChR turnover
AChRs migrate and turn over faster at DB/ synapses
than in controls, supporting the idea that DB acts in
part by tethering AChRs to the postsynaptic cytoskeleton
(Akaaboune et al., 2002). Because little is known about the

Synaptic localization of 1-syntrophin
and nitric oxide synthase
To further investigate mechanisms that might account for the
greater ability of DB1 than DB2 to support synaptic maturation, we studied the distribution of two proteins whose concentration at synaptic sites requires DB: 1-syntrophin and
neuronal nitric oxide synthase (nNOS). Levels of both are reduced synaptically and extrasynaptically in DB/ mice
(Grady et al., 2000). Moreover, 1-syntrophin mutants have
synaptic defects similar to those seen in DB/ mice (Adams
et al., 2000), and studies in vitro have implicated nNOS as a
modulator of AChR clustering (Jones and Werle, 2000).
In DB/,tgDB1 muscle, synaptic levels of 1-syntrophin and nNOS were similar to those in controls (Fig. 6). In
contrast, levels of 1-syntrophin and nNOS remained low
in many synapses of DB/,tgDB2 mice. Interestingly,
when viewed en face, DB/,tgDB2 synapses with the lowest levels of 1-syntrophin also had the most abnormal
AChR distribution (unpublished data). Thus, although either DB isoform can recruit 1-syntrophin and nNOS to
the NMJ, the increased efficacy of DB1 over DB2 in
maintaining synaptic architecture may reflect in part its increased recruiting ability.
Role of tyrosine phosphorylation in DB1 function
The COOH-terminal domain of DB1 is tyrosine phosphorylated in vivo (Balasubramanian et al., 1998), raising
the possibility that tyrosine phosphorylation is important
for its synaptic function. To test this idea, we fused GFP to
the NH2 terminus of DB1 (GFP-DB1) or to a mutant
form of DB1 in which the three major phosphorylated tyrosine residues (aa 698, 706, and 723 [Balasubramanian et
al., 1998]) had been changed to phenylalanine by sitedirected mutagenesis (GFP-DB1-P3). Expression of these
constructs in heterologous cells showed that only the GFPDB1 fusion protein underwent tyrosine phosphorylation
(Fig. 7 A). Thus, the addition of GFP to DB1 did not
preclude its phosphorylation, whereas the mutation of its
three tyrosine residues did. The two constructs were intro-
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molecular mechanisms that regulate AChR turnover, we
quantitated rBTX fluorescence in vivo (see Materials and
methods) to ask whether DB1 and DB2 had different effects on this process. Adult sternomastoid muscles were labeled with a single nonsaturating dose of rBTX, and individual synapses were imaged. 3 d later, the same synapses were
located and imaged again to assess changes in fluorescence
intensity. In wild-type mice, ⵑ20% of the labeled receptors
were lost from the cell surface after 3 d. This degree of loss
indicates a t1/2 of ⵑ10.5 d, similar to previous reports
(Akaaboune et al., 1999, 2002). In DB/ mice, nearly
60% of AChRs were lost over a similar time, indicating a t1/2
of ⵑ2.5 d (Fig. 5). AChR stability in DB/,tgDB1 mice
did not differ significantly from that of controls (t1/2 ⵑ9 d),
whereas the t1/2 of AChRs in DB/,tgDB2 mice was intermediate between controls and mutants (t1/2
ⵑ5.5 d).
Thus, consistent with the results on AChR distribution and
density, DB1 alone can support normal AChR turnover,
whereas DB2 is only partially effective.
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duced into tibialis anterior muscles of 2-wk-old DB/
mice by electroporation. Muscles were removed 10–14 d
later, transfected fibers were identified by GFP fluorescence, and their postsynaptic membranes were analyzed
(Fig. 7, B and C).
GFP-DB1 and GFP-DB1-P3 were expressed at equal
levels based on fluorescence intensity and were concentrated
at synaptic sites to a similar extent (Fig. 7 B), yet they affected AChR distribution in different ways. Expression of
GFP-DB1 in DB/ myofibers resulted in significant restoration of postsynaptic structure at most synaptic sites, and

AChR distribution was qualitatively normal at a subset of
NMJs (Fig. 7, D–F). Expression of GFP-DB1-P3 also restored AChR distribution to some extent, but the recovery
was significantly less than that seen with GFP-DB1 (p 
0.0001 by Chi-square test), and no synaptic sites appeared
normal (Fig. 7, D–F). The variability of “rescue” seen
among transfected fibers was greater than that seen in
DB/ transgenic mice, possibly because GFP interfered
with DB function or because electroporation led to variable protein levels. Nonetheless, these results indicate a role
for tyrosine phosphorylation in the function of DB1.

Downloaded from jcb.rupress.org on January 4, 2012

Figure 7. Impaired restoration of
postsynaptic structure in DBⴚ/ⴚ
muscle by DB1 that lacks tyrosine
phosphorylation sites. (A) Immunoblot of
HEK293 cells transfected with no DNA,
GFP-DB1, or GFP-DB1-P3 expression
constructs, lysed, and immunopurified
with anti-GFP antibodies. Cells
were treated with ( ) or without ()
pervanadate before lysis to inhibit tyrosine
phosphatases. Protein was identified
with either an anti-DB antibody (DB) or
an antiphosphotyrosine antibody (P-tyr).
Only GFP-DB1 from pervanadatetreated cells was tyrosine phosphorylated.
(B) Fiber bundles from DB/ skeletal
muscles that had been electroporated in
vivo with GFP-DB1 or GFP-DB1-P3 2 wk
earlier. After dissection, muscles were
stained with rBTX. Myofibers expressing
either fusion protein demonstrate similar
fluorescence along the entire sarcolemma
with concentrations at synaptic sites.
(C) High power images of synapses from
transfected muscle fibers showing that
both GFP-DB1 and GFP-DB1-P3 are
highly concentrated at synaptic sites.
(D) Muscle fibers stained with rBTX.
Expression of GFP-DB1 in DB/ muscle
leads to a qualitatively normal AChR
pattern with synaptic branches having
linear striations and relatively smooth
borders. GFP-DB1-P3 has less ability
to restore normal AChR distribution in
DB/ muscle with many synapses
having patchy clusters of AChRs and
fragmented branch borders. (E) High
power images of branches from
synapses such as those shown in D to
highlight differences in AChR patterning.
(F) Comparison of AChR distribution in
wild-type fibers (87 synapses), DB/
fibers (90 synapses), and in fibers
electroporated with GFP-DB1 (118
synapses) or GFP-DB1-P3 (161
synapses). Categories 1 and 4
were synapses typical of wild-type and
DB/ muscle, respectively; categories
2 and 3 were intermediate. Numbers
represent percentages of total synapses
examined. Approximately 70% of synapses in fibers expressing GFP-DB1 fell
into category 1 or 2 with 1% in category
4. In contrast, over 70% of synapses in
fibers expressing GFP-DB1-P3 fell into
category 3 or 4 with none in category 1.
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Interestingly, the qualitative differences between DB/
fibers transfected with GFP-DB1 and GFP-DB1-P3 paralleled the differences described above between DB/,
tgDB1 and DB/,tgDB2 fibers. Expression of DB1 either transgenically or by transfection resulted in postsynaptic sites with sharp, spicule-free borders and striated instead
of granular interiors. In contrast, although expression of either DB2 or GFP-DB1-P3 in DB/ muscle usually
led to restoration of sharp (spicule-poor) borders, interiors
remained granular (Fig. 4 B compared with Fig. 7 D).
These parallels suggest that the enhanced ability of DB1
over DB2 to support synaptic structure depends on its tyrosine phosphorylation.
The MTJ
In initial studies, we found that both DB1 and DB2 were
enriched at the MTJ in wild-type mice (Fig. 8). We therefore asked whether DB is required for the integrity of the

Figure 9. MTJ structure is abnormal
in DBⴚ/ⴚ mice and restored more
completely by DB1 than by DB2.
(A) Electron micrographs of MTJs from
wild-type, DB/, DB/,tgDB1, and
DB/,tgDB2 mice. Normal MTJs are
characterized by multiple folds with
long slender projections of muscle (M)
interdigitating with the collagen fibrils
of the tendon (T). In DB/ MTJs, folds
are shallower with blunted muscle
projections. In DB/,tgDB1 mice,
the MTJs appear similar to wild-type,
whereas in DB/,tgDB2 mice the MTJs
retain many features of DB/ MTJs.
(B) Measurements of MTJ folds revealed
that folds in DB/ MTJs (n 437 folds)
are half the size of normal folds (n 203).
Folds in DB/,tgDB1 MTJs (n 245)
were similar to controls, whereas those
of DB/,tgDB2 MTJs (n 230) were
intermediate between control and DB/.

MTJ. We used EM to address this issue. The muscle membrane at the MTJ is invaginated to form folds that run parallel to the myofiber’s long axis (Fig. 9 A). These folds, which
are deeper than those of the NMJ, create an interdigitation
with the collagen fibrils of the tendon. Folds were also
present at mutant MTJs but were significantly shorter than
those in controls (Fig. 9, difference between control and
DB/ p  0.0001 by ANOVA). Thus, DB is important
for maintaining normal MTJ architecture.
Based on these results, we asked whether DB1 and
DB2 differed in their ability to maintain MTJ structure. In
DB/,tgDB1 mice, the depth of the folds was not significantly different from wild-type (Fig. 9 B; p 0.25), whereas
folds in DB/,tgDB2 mice were significantly shorter than
those of wild-type or DB/,tgDB1 animals (p  0.0001).
Thus, DB1 was significantly more effective than DB2 in
maintaining the integrity of both MTJs and NMJs. Because
we could not identify transfected fibers in the electron mi-
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Figure 8. Localization of DB isoforms
at the MTJ. Sections of skeletal muscle
were stained with antibodies to DB1,
DB2, or both (pan-DB). (A) In wild-type
muscle, both DB1 and 2 were enriched
at the MTJ (arrowheads). (B) In DB/
muscle, both forms were absent. In both
DB/,tgDB1 and DB/,tgDB2 muscle,
transgene-encoded DB was restored to
the MTJ.
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croscope, we were unable to test whether DB1 phosphorylation plays a role in MTJ maintenance.

Discussion

The Journal of Cell Biology

Muscular dystrophy and DB
In normal muscle, DB2 is the predominant extrasynaptic
isoform, suggesting that it plays the primary role in helping
the DGC maintain muscle viability. Although we found
that expression of DB2 alone in DB/ mice prevented
muscle fiber degeneration, DB1 was equally capable. These
findings show that the unique COOH terminus of DB2 is
not required for its effect upon the membrane and suggest
that shared sequences suffice. Shared domains include sites
that mediate binding of DB to dystrophin and syntrophin.
Also included are two EF hand domains and a zinc finger region that can potentially mediate other protein–protein interactions (for review see Enigk and Maimone, 2001).
Ligands for these sites are unknown but may include novel
DB-binding proteins identified recently in yeast twohybrid screens (Benson et al., 2001; Mizuno et al., 2001;
Newey et al., 2001b). Thus, it is likely that both DB1 and
2 can maintain myofiber integrity by attracting similar binding partners to the DGC.
On the other hand, loss of DB1-specific functions at the
MTJ may contribute to muscle pathology. DB1 is better
able than DB2 to maintain the integrity of the MTJ. The
MTJ is the major site of force transmission from muscle fibers to the skeleton, and disruption of this structure may be
involved in the pathogenesis of some muscle disorders (Law
et al., 1995; Miosge et al., 1999). Previous studies have implicated the DGC in maintenance of the MTJ (Ridge et al.,
1994; Deconinck et al., 1997b), and our results suggest that
a main role of the DGC at this site may be to recruit DB1.
Localization of DB isoforms
In normal muscle, DB1 is selectively associated with the
NMJ and MTJ, but when overexpressed transgenically it was
capable of association with extrasynaptic membrane. We
therefore wondered what factors account for the normally
distinct distributions of the two isoforms. Analysis of mdx
mice has shown that the extrasynaptic localization of DB2
requires an intact DGC, so we considered the possibility that

DB and the NMJ
DB is a component of the molecular machinery that stabilizes AChRs within the postsynaptic membrane. In DB
mutants, the mobility of synaptic receptors is increased; as a
result, there is enhanced flux from the synapse to perijunctional regions, which are sites of AChR internalization
(Sanes and Lichtman, 2001; Akaaboune et al., 2002). This
mechanism could explain, at least in part, the appearance of
the DB/ postsynaptic membrane in which AChR turnover is abnormally high, density is low, and the distinction
between crests and troughs of junctional folds is blurred
(Grady et al., 2000; Akaaboune et al., 2002). Here, we show
that DB1 is better able than DB2 to rescue these synaptic
defects in DB/ mice, indicating that its unique COOH
terminus is important for DB’s synaptic function.
How might DB act? One possibility is that DB exerts
two distinct effects on the postsynaptic membrane, one mediated by common sequences and one by DB1-specific sequences. Alternatively, common sequences might mediate
all synaptic effects, with DB1-specific sequences serving to
enhance their efficacy. For example, even though regions
common to DB1 and 2 bind both utrophin and -syntrophin, there is some evidence that DB1 associates more
tightly with both proteins than does DB2 (Balasubramanian et al., 1998; Peters et al., 1998) (Fig. 6). These differences are likely to be relevant because AChR density is decreased in the absence of utrophin (Deconinck et al.,
1997a, Grady et al., 1997a) and mice lacking 1-syntrophin have postsynaptic defects similar to those in DB/
mice (Adams et al., 2000). Thus, sequences in the unique
COOH terminus of DB1 could enhance the ability of
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The DGC plays at least three distinct roles in muscle: maintaining sarcolemmal integrity and stabilizing the structure of
both the NMJ and the MTJ. Genetic studies in mice have
shown that loss of some DGC components affects one function and not others. For example, absence of dystrophin or
of -sarcoglycan results in muscular dystrophy with little
impact upon the NMJ (Hack et al., 1998; Grady et al.,
2000; Akaaboune et al., 2002). Conversely, mice lacking
utrophin or 1-syntrophin have abnormal synapses with no
detectable dystrophy (Deconinck et al., 1997a; Grady et al.,
1997a; Kameya et al., 1999; Adams et al., 2000). In contrast, DB is critical for all three DGC functions. In this paper, we show that DB’s disparate effects are explained in
part through alternative splicing of the DB transcript and
selective localization of the two main muscle isoforms,
DB1 and DB2.

the extrasynaptic localization of DB2 seen in normal mice
results from the preferential binding of DB2 over that of
DB1 to the DGC. This competition might be accentuated
by the higher levels of DB2 than DB1 seen in normal
muscle (Fig. 1 B). However, analysis of the DB/,tgDB1/
DB2 double transgenics, in which DB1 and DB2 were
expressed at similar levels, showed that DB1 was not dislodged from its extrasynaptic position by DB2. Thus the
extrasynaptic predominance of DB2 in normal muscle is
not likely to be a result of competition between the isoforms.
Other reasons for the selective distribution of the two isoforms include the possibility that DB1 might be selectively
transcribed from synaptic nuclei, analogous to the synaptic
expression of AChR subunits (for review see Sanes and Lichtman, 2001). This is unlikely, however, because both isoforms
appear to be transcribed from the same promoter (Newey et
al., 2001a). Two remaining potential explanations are as follows: First, there may be posttranscriptional localization of
DB1 mRNA either by synapse-specific stabilization of the
mRNA or by synapse-specific transport of the mRNA using
targeting information encoded in the 3 UTR (Newey et al.,
2001a). Second, DB3 might play a role. DB3 lacks the
syntrophin- and dystrophin-binding sites present in DB1
and 2 (Nawrotzki et al., 1998) but is nonetheless associated
with the DGC (Yoshida et al., 2000). Thus, in normal mice
DB3 may confine DB1 to the NMJ by blocking its access
to extrasynaptic-binding sites. This interaction would not occur in DB/,tgDB1 muscle, which lacks DB1–3.
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DB phosphorylation and synaptic plasticity
Replacement of three tyrosine residues in DB1’s unique
COOH-terminal domain by phenylalanine decreased its synaptic efficacy. These residues are the major, if not the only
sites of tyrosine phosphorylation in DB1 (Balasubramanian
et al., 1998) (Fig. 7 A). Our results, therefore, provide strong
evidence that DB1 function is modulated by phosphorylation. Phosphorylation might alter the conformation of neighboring sequences to affect their affinity for other proteins (as
suggested by modeling studies of Balasubramanian et al.,
1998) or may serve to recruit adaptor or signaling proteins as
occurs in numerous other phosphoproteins.
Our interest in DB1 phosphorylation stems from the
growing realization that even though mature synapses are remarkably stable, they are not inert. Instead, several of their
features, most notably the distribution and density of their
postsynaptic receptors, can change rapidly and dramatically
in response to altered input (Sheng and Lee, 2001). At the
NMJ, the t1/2 of AChRs increases, and their density begins
to decrease within 1 h after imposition of complete paralysis
(Akaaboune et al., 1999). AChR turnover and density are
similarly affected in DB/ mice, suggesting that DB is
part of the regulatory mechanism. However, actual loss of
DB is unlikely to be a physiological mechanism for such
rapid activity-dependent alterations. On the other hand, altered efficacy of DB1 by changes in its phosphorylation
state could affect AChR mobility quickly, reversibly, and in
an activity-dependent fashion.
Several tyrosine kinases have been implicated in postsynaptic structure: erbB and ephA kinases are concentrated in
the postsynaptic membrane; MuSK plays a critical role in
postsynaptic differentiation; src and fyn modulate AChR
stability in vitro; and trkB affects AChR distribution in vivo
(DeChiara et al., 1996; Gonzalez et al., 1999; Buonanno
and Fischbach, 2001; Lai et al., 2001; for review see Sanes
and Lichtman, 2001; Smith et al., 2001). It will be interesting to learn whether DB1 is a substrate for any of these kinases and whether activators of the kinases (neuregulin for
erbBs, ephrinA for ephA, agrin for MuSK, and BDNF for
trkB) affect DB1 phosphorylation. In addition, in view of
numerous reports implicating tyrosine kinases in central
synaptic plasticity and the presence of DGC components,
including DB and DB, at central synapses (Blake and
Kroger, 2000; Levi et al., 2002) it is intriguing to consider
the possibility that similar mechanisms act there.

Materials and methods
Generation of transgenic mice

To generate the DB1 expression vector, two cDNA clones (16.1A and
14.1.2 [Enigk and Maimone, 1999]) were isolated from a BC3H1 mouse
muscle cDNA library and ligated. The 3 end of the cDNA, including the
stop codon and ⵑ125 bp of the 3 UTR, was generated by RT-PCR from
mouse muscle RNA. The entire coding region was then subcloned first into
the SalI/NotI sites of pBK-RSV (Stratagene) and then into a pEtCAT vector,
which contains 3.3 kb of regulatory sequences from the mouse muscle creatine kinase gene, extending from 3,300 to 7 with respect to the transcriptional start site (Jaynes et al., 1988) (a gift from S. Hauschka, Univer-

sity of Washington, Seattle, WA). In addition, the vector contains an SV40/
polyadenylation sequence. To generate the DB2 expression vector, a fulllength clone was isolated from the BC3H1 library, subcloned into the
EcoRI site of pBluescript II SK( ) (Stratagene) and then into pEtCAT.
Linearized constructs were injected into C57BL6 oocytes at the Washington University Mouse Genetics Core. Four independent lines of mice
carrying the DB1 construct (tgDB1) and six independent lines carrying
the DB2 construct (tgDB2) were identified by PCR. Each line was bred
onto an DB/ background (Grady et al., 1999). DB/,tgDB1 line was
also bred to mdx mice and to DB/,tgDB2 mice.

Histology
For bright field microscopy, muscles were frozen in liquid nitrogen–cooled
isopentane and cross sectioned in a cryostat at 8 m; sections were stained
with hematoxylin and eosin. For immunohistochemistry, sections from the
same muscles were stained with primary antibody diluted in PBS/1% BSA/
2% normal goat serum for 2 h and then rinsed with PBS. Sections were
then incubated 1 h with a mixture of fluorescein-conjugated goat anti–rabbit IgG (Alexa 488; Molecular Probes) and rBTX (Molecular Probes), rinsed
in PBS, and mounted using 0.1% p-phenylenediamine in glycerol/PBS. For
en face views, sternomastoid muscles were fixed in 1% PFA in PBS for 20
min, cryoprotected in sucrose, frozen, and sectioned en face at 40 m.
Rabbit polyclonal antibodies to DB1 (DB638), DB2, and 1-syntrophin (SYN17) were gifts from Stanley Froehner, University of Washington
(Peters et al., 1997b). Rabbit polyclonal antibodies that recognize all forms
of DB (called pan-DB here) were generated using a recombinant fragment of DB and affinity purified using the immunogen (Grady et al.,
1997a). Rabbit polyclonal antibody to nNOS was purchased from Immunostar Inc. (no. 24287). Illustrations were prepared in Adobe Photoshop®.
For ultrastructural studies, tibialis anterior muscles were fixed in 4% glutaraldehyde/4% PFA in PBS, washed, refixed in 1% OsO4, dehydrated, and
embedded in resin. Thin sections were stained with lead citrate and uranyl
acetate. Sections were systematically scanned in the electron microscope,
and all MTJs encountered were measured from the micrographs. Muscles
from two to four animals were analyzed per genotype.

Immunoblotting
For immunoblots, sternomastoid muscle was homogenized and sonicated
in extraction buffer (PBS, 5 mM EDTA, 1% SDS, and protease inhibitors
[CompleteMini; Roche]). Protein concentration of whole muscle extract
was determined by a BCA protein assay (Pierce Chemical Co.). Equal
amounts of protein (50 g) were resolved on 7.5% SDS–polyacrylamide
gels and incubated with monoclonal antibody to DB (D62320; Transduction Laboratories). This antibody was detected with goat anti–mouse IgG1
peroxidase-conjugated secondary antibody (Roche) using ECL (NEN).

Quantitative fluorescence microscopy and in vivo imaging
AChR density at NMJs was calculated using the quantitative fluorescence
imaging technique described by Akaaboune et al. (1999, 2002). Briefly,
mice were anesthetized, and the exposed sternomastoid muscle was saturated with rBTX (5 g/ml) for 60 min, and superficial NMJs were viewed
with a fluorescence microscope. The fluorescence intensity at synapses was
compared with that of a nonbleaching fluorescent standard viewed concurrently. To study loss rate of AChRs, a nonblocking dose of rBTX (0.1 g/ml)
was applied to the sternomastoid for 2–5 min and 1 d later, after unbound
toxin had cleared, individual synapses were imaged. Total fluorescence intensity at the first view was expressed as 100%. Mice were then reexamined
3 d later, and total fluorescence intensity of the previously identified junctions was measured (Akaaboune et al., 1999). The use of a nonblocking
dose ensured that the turnover rate was not affected by paralysis.

Comparison of transgenic lines

Of the four DB1 transgenic lines examined on a DB/ background, two
(lines 12 and 14) expressed detectable DB1. More than 95% of muscle fibers expressed DB in line 12 but only 50–70% in line 14. However, both
lines were similar in that expression of the transgene prevented dystrophy
in transgene-positive fibers and led to a more normal synaptic structure
than observed in DB/,tgDB2 transgenic lines. Of the six DB2 lines examined, expression was detected in three (lines 11A, 11B, and 28). Results
from DB/,tgDB2 lines 11B and 28 were similar in all respects tested (muscle and synaptic structure and AChR turnover). Levels of transgene expression
were lower in line 11A, and only ⵑ70% of muscle fibers in DB/,tgDB2
line 11A mice were transgene positive. No central nuclei occurred in these
transgene-positive fibers, indicating rescue of the dystrophic phenotype,
but rescue of the synaptic phenotype was significantly less in this line than
in any of the other lines tested. In summary, all five transgenic lines tested
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common sequences to bind utrophin and syntrophin,
thereby enhancing DB1’s ability to stabilize the postsynaptic membrane.
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exhibited rescue of the dystrophic phenotype, and both tgDB1 lines rescued synaptic defects more effectively than any of the tgDB2 lines. Based
on these results, we studied DB/,tgDB1 line 12 and DB/,tgDB2 line
28 in greatest detail.

Expression vector GFP-DB1 was constructed by cloning the DB1 cDNA
described above into a pEGFP-C1 plasmid (CLONTECH Laboratories,
Inc.), generating a fusion protein with GFP attached to the NH2 terminus of
DB1. To create GFP-DB1-P3, PCR-directed mutagenesis was used to
change three terminal tyrosine residues (aa 698, 706, and 723) to phenylalanine. These residues correspond to aa 685, 693 and 710, which were
shown to be major if not sole sites of tyrosine phosphorylation in Torpedo
DB (Balasubramanian et al., 1998).
The DB1 constructs were transfected into HEK293 cells using Lipofectamine Plus transfection reagent (Invitrogen) and 4 g of DNA per 10cm dish. Cells were harvested 48 h after transfection. Immediately before
collection, cells were subjected to pervanadate stimulation to inhibit tyrosine phosphatases as described by Balasubramanian et al. (1998). Soluble
fractions were collected and immunopurified by incubating with GFP specific antibodies (A-11120; Molecular Probes) for 1 h at 4C, and then with
protein G sepharose beads (Amersham Biosciences) for 3 h more. Beads
were precipitated, washed, resuspended in 1 sample buffer, boiled for 4
min, and subjected to immunoblotting (see above). DB was detected using an mAb (D62320, Transduction Labs), and phosphotyrosine was detected using PY20 antibody (610000, Transduction Labs).
For in vivo electroporation, DNA was dissolved into normal saline
(0.9% NaCl) at a concentration of 2 g/l. Mice were anesthetized, and
their tibialis anterior muscles were injected transcutaneously with 25 l of
a 4 U/L bovine hyaluronidase/saline solution (Sigma-Aldrich) as recommended by McMahon et al. (2001). 2 h later, the mice were reanesthetized, the tibialis was exposed, injected with 25 l of DNA (50 g), and
electroporated (Aihara and Miyazaki, 1998). Electroporation was performed with a pair of 0.2-mm diameter stainless steel needle electrodes
(Genetronics) held 4 mm apart and inserted on either side of the injection
site parallel to the muscle fibers. Ten 80 V pulses, each 20 ms in duration,
were delivered at a frequency of 1 Hz, giving a field strength of ⵑ200 V/cm
(BTX electroporator). Muscles were dissected 10–14 d after injection and
fixed for 20 min in 1% PFA. Fiber bundles exhibiting GFP fluorescence
were isolated under a fluorescence dissecting microscope, stained with
rBTX and viewed by both light (Carl Zeiss MicroImaging, Inc.) and confocal (Olympus) microscopy.
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